Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 14 hours agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 20 minutes agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 6 days agovaccines will be available in the fall. The Vaccines and Related Biological Products Advisory...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 6 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 16 hours agoParticipants in the older group received either the new shot alone or Moderna's old COVID-19 vaccine...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 6 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
The Next COVID-19 Vaccine Is Coming. This Lineage of the Virus Is Its Likely Target.
US News & World Report· 6 days agoVaccine experts on Wednesday endorsed a new target for the next round of COVID-19 shots in the ongoing effort to protect against the ever-changing coronavirus. The
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days ago"Simply put, Novavax's Covid vaccine results have shown better tolerability cross-trial than mRNA ...
FDA Panel Backs Eli Lilly's Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 16 hours agoAll 11 members of the FDA's Peripheral and Central Nervous System Drugs Advisory Committee voted...